These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26526849)

  • 21. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
    Zhang L; Shih AY; Yang XV; Kuei C; Wu J; Deng X; Mani NS; Mirzadegan T; Sun S; Lovenberg TW; Liu C
    Mol Pharmacol; 2012 Dec; 82(6):1094-103. PubMed ID: 22930711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PyPLIF HIPPOS-Assisted Prediction of Molecular Determinants of Ligand Binding to Receptors.
    Istyastono EP; Yuniarti N; Prasasty VD; Mungkasi S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
    Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
    Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-silico guided discovery of novel CCR9 antagonists.
    Zhang X; Cross JB; Romero J; Heifetz A; Humphries E; Hall K; Wu Y; Stucka S; Zhang J; Chandonnet H; Lippa B; Ryan MD; Baber JC
    J Comput Aided Mol Des; 2018 Apr; 32(4):573-582. PubMed ID: 29582229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.
    Phatak SS; Gatica EA; Cavasotto CN
    J Chem Inf Model; 2010 Dec; 50(12):2119-28. PubMed ID: 21080692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A categorical structure-activity relationship analysis of GPR119 ligands.
    Kumar P; Carrasquer CA; Carter A; Song ZH; Cunningham AR
    SAR QSAR Environ Res; 2014; 25(11):891-903. PubMed ID: 25401513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for improved modeling of GPCR-drug complexes: blind predictions of serotonin receptors bound to ergotamine.
    Rodríguez D; Ranganathan A; Carlsson J
    J Chem Inf Model; 2014 Jul; 54(7):2004-21. PubMed ID: 25030302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective Use of Empirical Data for Virtual Screening against APJR GPCR Receptor.
    Manoliu LCE; Martin EC; Milac AL; Spiridon L
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational ensemble comparison for small molecules in drug discovery.
    Habgood M
    J Comput Aided Mol Des; 2018 Aug; 32(8):841-852. PubMed ID: 29987709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.